Prophylactic Evaluation of a Nipah Virus Monoclonal Antibody Medical Countermeasure

Project: Research project

Project Details

StatusFinished
Effective start/end date9/27/22 → 2/29/24

Funding

  • Mapp Biopharmaceutical, Inc.: $1,345,721.00